Description
GLP2-TZ is characterized as a dual receptor agonist with activity at both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The dual profile is the defining structural feature: single-receptor GLP-1 agonists and the triple agonists occupy separate positions in the same family, and the three are routinely compared rather than interchanged in receptor-potency work.
Investigated in in-vitro receptor binding and cAMP signaling assays for relative potency at its two targets. No human data is presented, referenced, or implied.
Supplied lyophilized for reconstitution in a laboratory setting. Identity confirmed by mass spectrometry; lot-specific purity and mass values are stated on the certificate of analysis.
Supplied strictly for laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or animal consumption, and not for diagnostic or therapeutic use. Purchase confirms the buyer is a qualified researcher and accepts sole responsibility for lawful handling, storage, and disposal under all applicable regulations.
Specifications
| CAS Number | 2023788-19-2 |
|---|---|
| Development code | LY3298176 |
| EC Number | 889-790-3 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813 g/mol |
| Amino acid count | 39 |
| Class | Dual GIP / GLP-1 receptor agonist |
| Purity | ≥99% RP-HPLC |
| Form | Lyophilized powder |
| Presentation | 10 vials × 10mg |
| Storage | −20°C, protect from light |
